Nov. 24 2025
Source Page: Cardiovascular risk assessment and lipid modificationOct. 01 2025
Source Page: Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapyOct. 01 2025
Source Page: Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapyOct. 01 2025
Source Page: Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapyOct. 01 2025
Source Page: Durvalumab for treating limited-stage small-cell lung cancer after platinum-based chemoradiotherapyOct. 01 2025
Source Page: Mirabegron for treating neurogenic detrusor overactivity in people 3 to 17 years (terminated appraisal)Oct. 01 2025
Source Page: Provider Selection Regime (PSR) annual summary for NHS EnglandSep. 30 2025
Source Page: Approved Particulars – notification of a hub and spoke arrangementSep. 29 2025
Source Page: Online consultations – frequently asked questions and support resourcesSep. 29 2025
Source Page: Five years of a greener NHS: progress and forward look